Objective:To assess the effect of the peroxisome proliferator-activated receptor (PPAR)-γ agonist rosigliotazone on the induction of endometriosis in a rat model.
Methods:Endometriosis was surgically induced in 28 rats by transplanting an autologous fragment of endometrial tissue onto the inner surface of the abdominal wall. Group I was assigned as control and no medication was administered. Starting 3 days before the operation and continuing for 4 weeks, 0.2 mg/kg/d rosiglitazone was administered to the study group orally. Four weeks later rats were killed and ectopic uterine tissues were evaluated morphologically and histologically. Scoring systems were used to evaluate preservation of epithelia.
Results:Four rats in the study group and one rat in the control group died of complications related to surgery. There was a significant difference in post-treatment spherical volumes (64.00 mm3 [interquartile range (IQR): 354.42] vs 41.60 mm3 [IQR: 37.87], P = .018) and explant weights (77.97 mg [IQR: 431.27] vs 47.24 mg [IQR: 43.01], P = .005) between control and rosiglitazone-treated groups. The epithelia were found to be preserved significantly better in the control group when compared with the roziglitazone-treated group (2.00 [IQR:2.00] vs 0.00 [IQR:2.25], P = .014).
Conclusions:Rosiglitazone was found to affect the induction of endometriosis negatively in this experimental rat model and seemed to interfere with the growth and maintenance of the uterine explant.
1. Strathy JH, Molgaard CA, Coulman CB. Endometriosis and infertility: A laparoscopic study of endometriosis among fertile and infertile women. Fertil Steril1982;38:667-672.
2.
2. Rice VM. Conventional medical therapies for endometriosis. Ann N Y Acad Sci2002;955:343-352.
3.
3. Sampson J. Periotneal endometriosis is due to the menstrual dissemination of endometrial tissue into the peritoneal cavity. Am J Obstet Gynecol1927;14:433-469.
4.
4. Halme J, Hammond MG, Hulka JF, Raj SG, Talbert LM., Retrograde menstruation in healthy women and in patients with endometriosis. Obstet Gynecol1984;64:151-154.
5.
5. Malinak LR, Buttram VC Jr, Elias S. Heritable aspects of endometriosis. Hum Reprod1980;6:544-549.
6.
6. Dmowski WP, Gebel HM, Braun DP. The role of cell-mediated immunity pathogenesis of endometriosis. Acta Obstet Gynecol Scand1994;15:7-14.
7.
7. Halme J, White C, Kauma S, Estes J, Haskill S. Periotneal macrophages from patients with endometriosis release growth factor activity in vitro. J Clin Endocrinol Metabol1988;66:1044-1049.
8.
8. Halme J, Becker S, Haskill S. Altered maturation and function of peritoneal macrophages: Possible role in pathogenesis of endometriosis. Am J Obstet Gynecol1987;156:783-789.
9.
9. Harada T, Yoshioka H, Yoshida S, et al. Increased interleukin-6 levels in periotoneal fluid of infertile patients with active endometriosis. Am J Obstet Gynecol1997;176:593-597.
10.
10. Harada T, Enatsu A, Mitsunari M, et al. Role of cytokines in progression of endometriosis. Gynecol Obstet Invest1999;47Suppl 1:34-39.
11.
11. Taylor RN, Ryan IP, Moore ES, Hornung D, Shifren JL, Tseng JF. Angiogenesis and macrophage activation in endometriosis. Ann NY Acad Sci1997;828:194-207.
12.
12. Ricote M, Huang JT, Welch JS, Glass CK. The peroxisome proliferator-activated receptor (PPAR-γ) as a regulator of monocyte/macrophage function. J Leukoc Biol1999;66:733-739.
13.
13. Vernon MW, Wilson EA. Studies on the surgical induction of endometriosis in the rat. Fertile Steril1985;44:684-694.
14.
14. Lebovic DI, Kir M, Casey CL. Peroxisome proliferator-activated receptor-gamma induces regression of endometrial explants in a rat model of endometriosis. Fertil Steril2004;82Suppl 3:1008-1013.
15.
15. Garcia-Velasco JA, Arici A, Zreik T, et al. Macrophage derived growth factors modulate Fas ligand expression in cultured endometrial stromal cells; A role in endomentriosis. Mol Hum Reprod1999;5:642-650.
16.
16. Lebovic DI, Bentzien F, Chao VA, Garrett EN, Meng YG, Taylor RN. Induction of an angiogenic phenotype in endometriotic stromal cell cultures by interleukin-1β. Mol Hum Reprod2000;6:2690-2675.
17.
17. Eisermann J, Gast MJ, Pineda J, et al. Tumor necrosis factor in peritoneal fluid of women undergoing laparoscopic surgery. Fertil Steril1988;50:573-579.
18.
18. Hill JA, Anderson DJ. Lymphocyte activity in the presence of periotoneal fluid from fertile women and infertile women with and without endometriosis. Am J Obstet Gynecol1989;161:861-864.
19.
19. Surrey ES, Halme J. Effect of platelet-derived growth factor on endomentrial stromal cell proliferation in vitro: A model for endometriosis?Fertil Steril1991;56:672-679.
20.
20. Rier SE, Zarmakoupis PN, Hu X, et al. Dysregulation of interleukin-6 responses in ectopic endometrial stromal cells: Correlation with decreased soluble receptor levels in peritoneal fluid of women with endometriosis. J Clin Endocrinol Metab1995;80:1431-1437.
21.
21. Ryan IP, Schriock ED, Taylor RN. Isolation, characterization, and comparison of human endometrial and endometriosis cells in vitro. J Clin Endocrinol Metab1994;78:642-649.
22.
22. Arici A, MacDonald Pc, Casey ML. Regulation of monocyte chemotactic prostein-1 gene expression in human endometrial cells in culture. Mol Cell Endocrinol1995;107:189-197.
23.
23. Hornung D, Dohrn K, Sotlar K, et al. Localization in tissues and secretion of eotaxin by cells from normal endometrium and endometriosis. J Clin Endocrinol Metab2000;85:2604-2608.
24.
24. Klein NA, Pergola GM, Tekmal RR. et al. Cytokine regulation of cellular proliferation in endometriosis. Ann N Y Acad Sci1994;734:322-332.
25.
25. Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK. The peroxisome prliferator-activated receptor-γ is a negative regulator of macrophage activation. Nature1998;391:79-82.
26.
26. Jiang C, Ting AT, Seed B. PPAR-γ agonists inhibit production of monocyte inflammatory cytokines. Nature1998;391:82-86.
27.
27. Singer CF, Marbaix E, Kokorine I, et al. Paracrine stimulation of interstitial collagenase (MMP-1) in the human endometrium by interleukin 1alpha and its dual block by ovarian steroids. Proc Natl Acad Sci U S A1997;94:10341-10345.
28.
28. Rana N, Braun DP, House R, Gebel H, Rotman C, Dmowski WP. Basal and stimulated secretion of cytokines by peritoneal macrophages in women with endometriosis. Fertil Steril1996;65:925-930.
29.
29. Gazvani MR, Christmas S, Quenby S, Kirwan J, Johnson PM, Kingland CR. Peritoneal fluid concentrations of interleukin-8 in women with endometriosis: Relationship to stage of disease. Hum Reprod1998;13:1957-1961.
30.
30. Lebovic DI, Baldocchi RA, Mueller MD, Taylor RN. Altered expression of a cell-cycle suppressor gene, Tob-1, in endometriotic cells by cDNA array analyses. Fertil Steril2002;78:849-854.
31.
31. Arici A, Oral E, Attar E, Tazuke SI, Olive DL. Monocyte chemotactic protein-1 concentration in peritoneal fluid of women with endomentrisois and its modulation of expression in mesothelial cells. Fertil Steril. 1997;67:1065-1072.
32.
32. Yee LD, Sabourin CL, Liu L,et al. Peroxisome proliferator-activated receptor gamma activation in human breast cancer. Int J Oncol1999;15:967-973.
33.
33. Houston KD, Copland JA, Broaddus RR, Gottardis MM, Fischer SM, Walker CL. Inhibition of proliferation and estrogen receptor signaling by peroxisome proliferator-activated recetor gamma ligands in uterine leiomyoma. Cancer Res2003;63:1221-1227.
34.
34. Heaney AP, Fernando M, Melmed S. PPAR-gamma receptor ligands: Novel therapy for pituitary adenomas. J Clin Invest2003;111:1381-1388.
35.
35. Sharpe KL, Zimmer RL, Khan RS, Penney LL. Proliferative and morphogenic changes induced by the coculture of rat uterine and perioneal cells: A cell culture model for endometriosis. Fertil Steril1992;58:1220-1229.
36.
36. Sharpe KL, Zimmer RL, Griffin WT, Penney LL. Polypeptides synthesized and released by human endometriosis differ from those of the uterine endometrium in cell and tissue explant culture. Fertil Steril1993;60:839-851.
37.
37. Isaacson KB, Xu Q, Lyttle CR. The effect of estradiol on the production and secretion of complement component 3 by the rat uterus and surgically induced endometriotic tissue. Fertil Steri. 1991;55:395-402.
